Vertex Pharmaceuticals (VRTX) Net Income Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 37.58 Bn | 34.57 Bn | 959.66 Mn | 1,228.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.59% |
| Dec 31, 2025 | 30.46% |
| Sep 30, 2025 | 3.59% |
| Jun 30, 2025 | 128.74% |
| Mar 31, 2025 | -41.22% |
| Dec 31, 2024 | -5.76% |
| Sep 30, 2024 | 0.98% |
| Jun 30, 2024 | -492.44% |
| Mar 31, 2024 | 57.13% |
| Dec 31, 2023 | 18.31% |
| Sep 30, 2023 | 11.26% |
| Jun 30, 2023 | 12.98% |
| Mar 31, 2023 | -8.17% |
| Dec 31, 2022 | 6.34% |
| Sep 30, 2022 | 9.23% |
| Jun 30, 2022 | 1,109.70% |
| Mar 31, 2022 | 16.69% |
| Dec 31, 2021 | 27.46% |
| Sep 30, 2021 | 27.64% |
| Jun 30, 2021 | -92.00% |